Skip to main content

Diagnostic options ยท UAE

Microbiology tests in Dubai & UAE

Compare available Microbiology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

299

Listed price range

490.00โ€“5,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Microbiology test prices

Showing 151โ€“165 of 299 matching tests.

Microbiology diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-811
Human Rotavirus RNA Detection (Qualitative) Test

This test detects the presence of human rotavirus RNA in a stool sample using Real-Time PCR.

Stool (feces) 36 hours (phone) / 48 hours (email) 1,000.00 AED
View
View test specifications and preparation
What it measures
["Human Rotavirus RNA"]
Parameters
[]
Preparation
["No specific fasting required", "Collect stool sample in a sterile container"]
Indications
["Suspected rotaviral gastroenteritis", "Diagnosis in children under five", "Diagnosis in immunocompromised adults", "Outbreak investigation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 56905-3 ICD-10: A08.0
Clinical summary
This test detects the presence of human rotavirus RNA in a stool sample using Real-Time PCR.
TEST-810
Human Rotavirus Viral Load Quantitative Test

This diagnostic test evaluates the quantity of human rotavirus RNA present in a stool sample.

Stool (fresh sample in sterile container) 24 โ€“ 36 hours (results phoned) / 48 hours (email report) 1,200.00 AED
View
View test specifications and preparation
What it measures
["Human Rotavirus RNA concentration", "Viral Load (RNA copies/mL)"]
Parameters
[{"name": "Rotavirus RNA Viral Load", "reference_range": "Quantitative (RNA copies/mL)"}]
Preparation
["No special preparation required", "No fasting needed", "No medication adjustment required"]
Indications
["Diagnosis of active rotavirus infection", "Monitoring disease severity", "Differentiating active infection from asymptomatic shedding", "Guiding infection control protocols", "Monitoring antiviral therapy efficacy in immunocompromised patients"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49936-0 ICD-10: A08.0
Clinical summary
This diagnostic test evaluates the quantity of human rotavirus RNA present in a stool sample.
TEST-2068
Immunohistochemistry Polyoma BK Virus (SV40) Test

This test detects the presence of BK virus large T-antigen in kidney tissue biopsies.

Archival Tissue Specimen โ€” Formalin-Fixed Paraffin-Embedded (FFPE) Kidney Biopsy Block or Unstained Slides 5โ€“7 working days 600.00 AED
View
View test specifications and preparation
What it measures
["Intracellular viral antigen (BK virus large T-antigen)", "Cross-reactive SV40 antigen"]
Parameters
[]
Preparation
["Provide histopathology report", "Provide biopsy site details", "Provide full clinical history", "Temporary discontinuation of blood thinners may be ordered under medical supervision"]
Indications
["Suspected BK virus nephropathy in renal transplant patients", "Differential diagnosis of graft rejection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 69061-0 ICD-10: B97.8
Clinical summary
This test detects the presence of BK virus large T-antigen in kidney tissue biopsies.
TEST-46
Infectious Disease Check Profile Test

This test evaluates for the presence of multiple infectious agents, including viruses, bacteria, and fungi, using advanced molecular and serological methods.

Serum + Nasopharyngeal swab + Whole blood 7 calendar days; critical values reported within 48 hours 1,100.00 AED
View
View test specifications and preparation
What it measures
["Viral pathogens (e.g., HIV, COVID-19, EBV, CMV)", "Bacterial pathogens", "Fungal pathogens", "Antibodies (serological markers)", "Genetic material (molecular markers)"]
Parameters
[{"name": "HIV", "reference_range": "Non-reactive"}, {"name": "COVID-19", "reference_range": "Negative"}, {"name": "Hepatitis Panel", "reference_range": "Non-reactive / Negative"}, {"name": "Epstein-Barr Virus", "reference_range": "Non-reactive / Negative"}, {"name": "Cytomegalovirus", "reference_range": "Non-reactive / Negative"}]
Preparation
["No fasting required.", "Inform phlebotomist about recent vaccinations, blood transfusions, or immunomodulatory medications (past 30 days)."]
Indications
["Screening for HIV", "Screening for COVID-19", "Screening for Hepatitis panel", "Screening for Epstein-Barr virus", "Screening for Cytomegalovirus", "Screening for other regionally prevalent infectious agents"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60567-5 ICD-10: Z11.9
Clinical summary
This test evaluates for the presence of multiple infectious agents, including viruses, bacteria, and fungi, using advanced molecular and serological methods.
TEST-588
Influenza A (H1N1) pdm09 (Swine Flu) & Human RNase P RNA Detection Test

This test detects the presence of Influenza A (H1N1) pdm09 viral RNA in a respiratory specimen using real-time PCR. It also includes an internal control (human RNase P) to ensure s...

Nasopharyngeal swab / aspirate Preliminary result by phone within 24 hours; official DHA-compliant PDF report within 36 hours. 700.00 AED
View
View test specifications and preparation
What it measures
["Influenza A (H1N1) pdm09 viral RNA", "Human RNase P RNA (internal control)"]
Parameters
[]
Preparation
[]
Indications
["Suspected influenza infection, particularly H1N1 strain", "Epidemiological surveillance during flu season", "Diagnosis in patients with severe respiratory illness", "Confirmation of suspected cases in outbreaks"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55466-5 ICD-10: J09.X2
Clinical summary
This test detects the presence of Influenza A (H1N1) pdm09 viral RNA in a respiratory specimen using real-time PCR. It also includes an internal control (human RNase P) to ensure sample quality.
TEST-796
Influenza A (RNA Detection), Qualitative Test

This diagnostic test detects the presence of Influenza A viral RNA in a nasopharyngeal sample.

Nasopharyngeal Swab (NP Swab) Phone notification within 24 hours; formal report within 36 hours 550.00 AED
View
View test specifications and preparation
What it measures
["Influenza A viral RNA"]
Parameters
[]
Preparation
[]
Indications
["Onset of flu-like symptoms", "Known exposure to influenza A", "Need for rapid diagnosis for treatment decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92141-2 ICD-10: J10.1
Clinical summary
This diagnostic test detects the presence of Influenza A viral RNA in a nasopharyngeal sample.
TEST-851
Influenza A & H3N2 RNA Qualitative Test

This test detects the presence of viral RNA from Influenza A, including the H3N2 subtype, in respiratory specimens.

Nasopharyngeal or Oropharyngeal Swab Phone result in 24 hours; full report in 36 hours 1,100.00 AED
View
View test specifications and preparation
What it measures
["Influenza A viral RNA", "H3N2 subtype viral RNA"]
Parameters
[]
Preparation
["No fasting required", "Sign electronic consent form", "Provide relevant clinical history"]
Indications
["Suspected influenza infection", "Need for specific subtype identification (H3N2)", "Guiding antiviral therapy", "Distinguishing influenza from other respiratory pathogens"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34487-9 ICD-10: J10.1
Clinical summary
This test detects the presence of viral RNA from Influenza A, including the H3N2 subtype, in respiratory specimens.
TEST-803
Influenza A Viral Load Quantitative Test

This test measures the amount of Influenza A virus RNA in a respiratory sample.

Nasopharyngeal swab / Respiratory specimen 24โ€“36 hours 600.00 AED
View
View test specifications and preparation
What it measures
["Influenza A viral RNA load"]
Parameters
[]
Preparation
["No fasting required", "No dietary restrictions", "No medication changes required"]
Indications
["Monitoring antiviral therapy response", "Assessing treatment efficacy in severe influenza", "Monitoring immunocompromised patients with persistent symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 40579-1 ICD-10: J10.1
Clinical summary
This test measures the amount of Influenza A virus RNA in a respiratory sample.
TEST-792
Influenza B (RNA Detection) Qualitative Test

This test detects the presence of Influenza B viral RNA in a nasopharyngeal or throat swab sample.

Nasopharyngeal swab (or throat swab if contraindicated) 24 hours (phone notification) / 36 hours (email report) 550.00 AED
View
View test specifications and preparation
What it measures
["Influenza B viral RNA", "Presence of active Influenza B infection"]
Parameters
[]
Preparation
["No fasting required", "Continue all prescribed medications", "Inform phlebotomist about anticoagulant use or recent nasal sprays"]
Indications
["Suspected influenza B infection", "High-risk patients (e.g., elderly, immunocompromised)", "Differentiation from Influenza A or bacterial infections", "Guidance for antiviral therapy", "Compliance with UAE DHA respiratory panels"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34487-9 ICD-10: J10.1
Clinical summary
This test detects the presence of Influenza B viral RNA in a nasopharyngeal or throat swab sample.
TEST-799
Influenza B Viral Load Quantitative Test

This diagnostic test evaluates the quantity of Influenza B virus RNA in a respiratory sample.

Nasopharyngeal Swab / Respiratory Secretion 3rd working day (email), preliminary phone alert in 24h 600.00 AED
View
View test specifications and preparation
What it measures
["Influenza B RNA copies per millilitre", "Viral load quantification"]
Parameters
[{"name": "Influenza B Viral Load", "reference_range": null}]
Preparation
[]
Indications
["High-risk patients", "Hospitalised cases", "Immunocompromised individuals", "Antiviral dosing guidance", "Hospital discharge decisions", "Epidemic monitoring"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49580-4 ICD-10: J10.1, J11.1
Clinical summary
This diagnostic test evaluates the quantity of Influenza B virus RNA in a respiratory sample.
TEST-790
Influenza Group A & B (RNA Detection) Qualitative Test

This test detects the presence of genetic material (RNA) from Influenza A and B viruses in a nasopharyngeal sample.

Nasopharyngeal Swab 24 hours (phone) / 36 hours (email) 600.00 AED
View
View test specifications and preparation
What it measures
["Influenza A viral RNA", "Influenza B viral RNA"]
Parameters
[]
Preparation
["Avoid using nasal sprays or decongestants for at least 30 minutes prior to collection.", "A signed consent form and brief clinical history are required."]
Indications
["Suspected influenza infection", "Differential diagnosis of respiratory illness", "Confirmation of rapid antigen test results", "Public health surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76077-8 ICD-10: J10.1, J11.1
Clinical summary
This test detects the presence of genetic material (RNA) from Influenza A and B viruses in a nasopharyngeal sample.
TEST-794
Influenza Group A & B Viral Load Quantitative Test

This test quantifies the amount of Influenza A and B viral RNA present in a sample.

Nasopharyngeal or Oropharyngeal Swab 24 h (phone) / 36 h (email) 700.00 AED
View
View test specifications and preparation
What it measures
["Influenza A viral RNA concentration", "Influenza B viral RNA concentration"]
Parameters
[]
Preparation
["Avoid nasal decongestant sprays or antiseptic mouthwashes for at least 2 hours before swab collection.", "Stop high-dose biotin (>5 mg/day) 72 hours prior if advised by your physician."]
Indications
["Diagnosis of influenza in high-risk patients", "Monitoring treatment response", "Infection control in congregate settings", "Evaluating antiviral efficacy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76081-7 ICD-10: J10.8, J11.1
Clinical summary
This test quantifies the amount of Influenza A and B viral RNA present in a sample.
TEST-2249
Influenza-Like Illness (ILI) and SARS-CoV-2 Panel Test

This diagnostic test evaluates for the presence of Influenza A, Influenza B, and SARS-CoV-2 viruses using molecular methods.

Nasopharyngeal Swab 2 Days 1,500.00 AED
View
View test specifications and preparation
What it measures
["Influenza A virus RNA", "Influenza B virus RNA", "SARS-CoV-2 virus RNA"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the phlebotomist of any recent nasal surgery or bleeding disorders."]
Indications
["Patients presenting with symptoms of influenza-like illness.", "Differential diagnosis between influenza and COVID-19.", "Confirmation of SARS-CoV-2 infection.", "Travel clearance requirements."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60553-7 ICD-10: J06.9, J12.81, U07.1
Clinical summary
This diagnostic test evaluates for the presence of Influenza A, Influenza B, and SARS-CoV-2 viruses using molecular methods.
TEST-2274
Interleukin-6 (IL-6) SARS-CoV-2 Advanced Panel Test

This diagnostic test evaluates the body's inflammatory and coagulation response to SARS-CoV-2 infection, assessing the risk of severe disease progression.

Peripheral venous blood (serum/plasma) and nasopharyngeal swab 2 days from sample receipt 1,900.00 AED
View
View test specifications and preparation
What it measures
["Interleukin-6 (IL-6) levels", "SARS-CoV-2 RNA", "Coagulation factors (Prothrombin time, D-dimer, Platelet count)"]
Parameters
[{"name": "Interleukin-6 (IL-6)", "reference_range": null}, {"name": "SARS-CoV-2 RNA", "reference_range": null}, {"name": "Prothrombin Time (PT)", "reference_range": null}, {"name": "D-dimer", "reference_range": null}, {"name": "Platelet Count", "reference_range": null}]
Preparation
["Discontinue biotin supplements at least 8 hours before collection", "Overnight fasting is recommended but not mandatory"]
Indications
["Early identification of hyperinflammatory responses in COVID-19", "Assessment of risk for severe disease progression", "Guidance for immunomodulatory therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3390-4 ICD-10: U07.1
Clinical summary
This diagnostic test evaluates the body's inflammatory and coagulation response to SARS-CoV-2 infection, assessing the risk of severe disease progression.
TEST-369
ITS Sequencing Test

This test identifies fungal species present in a sample using Next-Generation Sequencing of the ITS region.

Whole blood (EDTA), extracted DNA, fresh/frozen tissue 3 weeks 800.00 AED
View
View test specifications and preparation
What it measures
["Fungal DNA", "Internal Transcribed Spacer (ITS) region sequences"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any current antifungal or immunosuppressive medications"]
Indications
["Suspected invasive fungal infection", "Immunocompromised patients", "Inconclusive results from conventional fungal culture", "Need for species-level identification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 31717-4 ICD-10: B49, B37.8, B44.8
Clinical summary
This test identifies fungal species present in a sample using Next-Generation Sequencing of the ITS region.

Category overview

Microbiology: overview

Uncovering the hidden causes of illness is the essential first step toward targeted treatment and restoring your peace of mind. The Microbiology division at DNA Labs UAE employs advanced automated culturing and antimicrobial susceptibility technologies to identify specific microscopic pathogens accurately. By pinpointing the exact bacteria or fungi involved, our comprehensive microbiology testing in the UAE serves as a vital guide for your doctorโ€™s clinical decision-making. Operating as a premier diagnostic lab in Dubai/UAE, we guarantee the highest standards of data security and strict confidentiality, delivering fast, highly accurate results you can rely on. Take the guesswork out of your recovery. Browse our microbiology diagnostic tests, schedule a convenient home collection, or speak with our laboratory experts today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area